<DOC>
	<DOCNO>NCT02121340</DOCNO>
	<brief_summary>In feasibility/pilot study , develop , refine , evaluate feasibility novel mental health/ophthalmologic intervention call , `` Collaborative Care Depression Diabetic Retinopathy '' ( CC-DDR ) , aim treat depression lower HbA1C old African Americans mild-to-moderate diabetic retinopathy ( DR ) comorbid depression .</brief_summary>
	<brief_title>Collaborative Care Depression Diabetic Retinopathy African Americans</brief_title>
	<detailed_description>The Specific Aims : 1 . To develop CC-DDR treatment protocol . This involve : 1 . Creating initial version CC-DDR treatment protocol . 2 . Refining protocol base input expert panel expertise DR , depression , culturally relevant intervention diabetes old African Americans . 3 . Developing tool assess interventionist treatment adherence competence . 2 . To conduct open trial CC-DDR 40 participant poorly control diabetes , depression , mild moderate DR. During open trial : 1 . Evaluate feasibility CC-DDR . 2 . Refine CC-DDR treatment protocol incorporate feedback participant , community health care worker ( CHWs ) , ophthalmologist , expert panel . 3 . Refine procedure recruitment retention , outcome assessment , monitor treatment fidelity , CHW train supervision , quality assurance , study administration , base input investigator , CHWs , participant , expert panel . 4 . Examine CC-DDR 's impact depression severity ; diabetes self-management practice ; HbA1C level ; blood pressure ; adherence ophthalmologist treatment plan ; vision function ; quality life ; satisfaction CC-DDR . 3 . To complete Manual Procedures characterize aspect plan efficacy trial CC-DDR .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>1 . AfricanAmerican race 2. age ≥ 65 year 3. type 2 diabetes 4. mild moderate nonproliferative DR without macular edema 5. depressive symptom ( i.e. , Patient Health Questionnaire9 score ≥5 ) 6 . HbA1C ≥ 7.0 % 1. treated proliferative DR 2. global cognitive impairment ( i.e. , Mini Mental Status score ≤ 20 ) 3. psychiatric diagnosis depression 4. treatment depression start previous 3 month 5. life expectancy 2 year</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Health disparity</keyword>
	<keyword>African American</keyword>
	<keyword>Geriatric</keyword>
</DOC>